| Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications IP Trougakos, K Stamatelopoulos, E Terpos, OE Tsitsilonis, E Aivalioti, ... Journal of Biomedical Science 28, 1-18, 2021 | 342 | 2021 |
| Harnessing the immune system to improve cancer therapy NE Papaioannou, OV Beniata, P Vitsos, O Tsitsilonis, P Samara Annals of translational medicine 4 (14), 2016 | 335 | 2016 |
| Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor CN Baxevanis, IF Voutsas, OE Tsitsilonis, AD Gritzapis, R Sotiriadou, ... The Journal of Immunology 164 (7), 3902-3912, 2000 | 211 | 2000 |
| VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2 AC Ziogas, NG Gavalas, M Tsiatas, O Tsitsilonis, E Politi, E Terpos, ... International journal of cancer 130 (4), 857-864, 2012 | 168 | 2012 |
| VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2 NG Gavalas, M Tsiatas, O Tsitsilonis, E Politi, K Ioannou, AC Ziogas, ... British journal of cancer 107 (11), 1869-1875, 2012 | 166 | 2012 |
| Compromised anti‐tumor responses in tumor necrosis factor‐α knockout mice CN Baxevanis, IF Voutsas, OE Tsitsilonis, ML Tsiatas, AD Gritzapis, ... European journal of immunology 30 (7), 1957-1966, 2000 | 123 | 2000 |
| Correlation of NK T-like CD3+ CD56+ cells and CD4+ CD25+ (hi) regulatory T cells with VEGF and TNFα in ascites from advanced ovarian cancer: Association with platinum … A Bamias, V Koutsoukou, E Terpos, ML Tsiatas, C Liakos, O Tsitsilonis, ... Gynecologic oncology 108 (2), 421-427, 2008 | 119 | 2008 |
| Oxidative stress-mediated biomolecular damage and inflammation in tumorigenesis F Sesti, OE Tsitsilonis, A Kotsinas, IP Trougakos In Vivo 26 (3), 395-402, 2012 | 115 | 2012 |
| Expression of alpha-thymosins in human tissues in normal and abnormal growth. OE Tsitsiloni, J Stiakakis, A Koutselinis, J Gogas, C Markopoulos, ... Proceedings of the National Academy of Sciences 90 (20), 9504-9507, 1993 | 94 | 1993 |
| Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+ CD56+ cells with … A Bamias, ML Tsiatas, E Kafantari, C Liakou, A Rodolakis, Z Voulgaris, ... Gynecologic oncology 106 (1), 75-81, 2007 | 93 | 2007 |
| HER‐2/neu–derived peptide epitopes are also recognized by cytotoxic CD3+CD56+ (natural killer T) lymphocytes CN Baxevanis, AD Gritzapis, OE Tsitsilonis, HL Katsoulas, M Papamichail International journal of cancer 98 (6), 864-872, 2002 | 60 | 2002 |
| Toll-like receptor agonists: current status and future perspective on their utility as adjuvants in improving antic ancer vaccination strategies CN Baxevanis, IF Voutsas, OE Tsitsilonis Immunotherapy 5 (5), 497-511, 2013 | 58 | 2013 |
| Immunogenic cell death, DAMPs and prothymosin α as a putative anticancer immune response biomarker AI Birmpilis, A Paschalis, A Mourkakis, P Christodoulou, IV Kostopoulos, ... Cells 11 (9), 1415, 2022 | 55 | 2022 |
| Polar Constituents of Marrubium thessalum Boiss. & Heldr. (Lamiaceae) and their Cytotoxic/Cytostatic Activity A Argyropoulou, P Samara, O Tsitsilonis, H Skaltsa Phytotherapy Research 26 (12), 1800-1806, 2012 | 55 | 2012 |
| Prothymosin alpha: a ubiquitous polypeptide with potential use in cancer diagnosis and therapy K Ioannou, P Samara, E Livaniou, E Derhovanessian, OE Tsitsilonis Cancer Immunology, Immunotherapy 61, 599-614, 2012 | 55 | 2012 |
| Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone E Kastritis, I Dialoupi, M Gavriatopoulou, M Roussou, N Kanellias, ... Blood advances 3 (20), 3002-3009, 2019 | 52 | 2019 |
| Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis E Kastritis, IV Kostopoulos, E Terpos, B Paiva, D Fotiou, M Gavriatopoulou, ... Blood cancer journal 8 (5), 46, 2018 | 51 | 2018 |
| Selective cytotoxicity of the herbal substance acteoside against tumor cells and its mechanistic insights C Cheimonidi, P Samara, P Polychronopoulos, EN Tsakiri, T Nikou, ... Redox Biology 16, 169-178, 2018 | 50 | 2018 |
| Cytotoxicity and immunomodulating characteristics of labdane diterpenes from Marrubium cylleneum and Marrubium velutinum A Karioti, M Skopeliti, O Tsitsilonis, J Heilmann, H Skaltsa Phytochemistry 68 (11), 1587-1594, 2007 | 50 | 2007 |
| Development and immunochemical evaluation of antibodies Y for the poorly immunogenic polypeptide prothymosin alpha P Klimentzou, M Paravatou-Petsotas, C Zikos, A Beck, M Skopeliti, ... Peptides 27 (1), 183-193, 2006 | 49 | 2006 |
